Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Nov 25, 2016 $23.50 $23.50 $23.00 $23.00 3 466
Nov 23, 2016 $23.50 $24.00 $23.00 $23.00 10 215
Nov 22, 2016 $24.70 $25.00 $23.50 $23.50 6 856
Nov 21, 2016 $24.00 $25.00 $23.50 $24.50 5 887
Nov 18, 2016 $26.00 $26.50 $24.00 $24.00 15 253
Nov 17, 2016 $23.00 $26.50 $22.00 $26.00 26 324
Nov 16, 2016 $24.50 $25.50 $23.00 $23.00 14 051
Nov 15, 2016 $25.50 $25.50 $23.00 $25.00 14 856
Nov 14, 2016 $20.50 $25.50 $20.00 $25.50 27 478
Nov 11, 2016 $19.50 $21.00 $19.50 $20.00 15 106
Nov 10, 2016 $20.00 $20.50 $19.50 $20.00 14 366
Nov 09, 2016 $20.00 $22.00 $19.20 $20.00 25 524
Nov 08, 2016 $20.00 $20.00 $20.00 $20.00 7 347
Nov 07, 2016 $20.00 $20.00 $20.00 $20.00 6 000
Nov 04, 2016 $19.50 $19.50 $19.50 $19.50 8 710
Nov 03, 2016 $19.50 $19.50 $19.50 $19.50 9 100
Nov 02, 2016 $21.50 $21.50 $21.50 $21.50 25 400
Nov 01, 2016 $19.00 $19.00 $19.00 $19.00 11 350
Oct 31, 2016 $20.50 $20.50 $20.50 $20.50 5 140
Oct 28, 2016 $20.00 $20.00 $20.00 $20.00 8 780
Oct 27, 2016 $21.00 $21.00 $21.00 $21.00 9 400
Oct 26, 2016 $22.50 $22.50 $22.50 $22.50 12 250
Oct 25, 2016 $21.50 $21.50 $21.50 $21.50 10 250
Oct 24, 2016 $22.50 $22.50 $22.50 $22.50 7 880
Oct 21, 2016 $23.00 $23.00 $23.00 $23.00 5 430
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT